Advertisement

Topics

Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug

10:00 EDT 23 May 2011 |

[Update: 12:03 pm ET, with pricing info] Vertex’s big day has arrived. The Cambridge, MA-based biotech company has gotten clearance from the FDA to start marketing telaprevir (Incivek) as a new treatment for patients in the U.S. with hepatitis C. The new drug, a protease inhibitor designed to fight the liver-damaging virus, is now approved [...]

Original Article: Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug

NEXT ARTICLE

More From BioPortfolio on "Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...